Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia.
Blood
; 119(12): 2854-62, 2012 Mar 22.
Article
in En
| MEDLINE
| ID: mdl-22308293
Full text:
1
Database:
MEDLINE
Main subject:
Vidarabine
/
Leukemia, Lymphocytic, Chronic, B-Cell
/
Tumor Suppressor Protein p53
/
Drug Resistance, Neoplasm
/
Inhibitor of Apoptosis Proteins
/
Antineoplastic Agents
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2012
Type:
Article